These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5726584)

  • 1. Serum complement in systemic lupus erythematosus (SLE).
    Asano S; Marumo K; Igaki Y; Toyoizumi E; Okubo M
    Arerugi; 1968 Jul; 17(7):597-609. PubMed ID: 5726584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fluctuation of serum complement activities in systemic lupus erythematosus and its clinical significance].
    Okuda M
    Naika; 1970 Feb; 25(2):353-8. PubMed ID: 5309587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 4. Family studies of B lymphocyte alloantigens in systemic lupus erythematosus.
    Reinersten JL; Klippel JH; Johnson AH; Steinberg AD; Decker JL; Mann DL
    J Rheumatol; 1982; 9(2):253-62. PubMed ID: 6980280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between serum complement titer (CH50), immune adherence (IA), beta-1-A-globulin, transferrin, IgA, IgM and IgG in SLE].
    Ishikawa Y
    Arerugi; 1969 Dec; 18(12):966-72. PubMed ID: 4189140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
    Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
    [No Abstract]   [Full Text] [Related]  

  • 8. [Whole serum complement in kidney diseases and systemic lupus erythematosus].
    Stein G; Stelzner A; Tanner E
    Z Gesamte Inn Med; 1973 Aug; 28(16):469-76. PubMed ID: 4129087
    [No Abstract]   [Full Text] [Related]  

  • 9. [Exploration of the route of complement activation in idiopathic membranoproliferative glomerulonephritis and lupic nephropathy].
    Gutiérrez Millet V; Prieto C; Ortuño MT; Usera G; Jarillo MD; Ruilope LM; Rodicio JL
    Rev Clin Esp; 1978 Nov; 151(3):223-8. PubMed ID: 740997
    [No Abstract]   [Full Text] [Related]  

  • 10. When to perform a renal biopsy in systemic lupus erythematosus (SLE)? A retrospective analysis of the correlation between morphological findings and clinical data at the time of biopsy.
    Sluiter HE; Kallenberg CG; Van Son WJ; Weening JJ; Van der Meulen J; The TH; Van der Hem GK
    Neth J Med; 1981; 24(6):217-23. PubMed ID: 6976520
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythrosedimentation and serum complement as parameters of clinical activity in systemic lupus erythematosus.
    Rivero I; Moravenik M; Diumenjo MS; Vannucci J
    Rev Clin Esp; 1977 Dec; 147(5):495-8. PubMed ID: 605255
    [No Abstract]   [Full Text] [Related]  

  • 12. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
    Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
    J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum complement determinations in patients with quiescent systemic lupus erythematosus.
    Sullivan KE; Wisnieski JJ; Winkelstein JA; Louie J; Sachs E; Choi R; Veksler E; Goldman D; Petri M
    J Rheumatol; 1996 Dec; 23(12):2063-7. PubMed ID: 8970042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
    Via CS; Allen RC; Welton RC
    J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between various autoimmune antibodies and serum complement levels in patients with systemic lupus erythematosus].
    Okumura N; Kumagai T; Kameko M; Kanai M
    Rinsho Byori; 1986 Aug; 34(8):967-72. PubMed ID: 3784036
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective complete Clq deficiency associated with systemic lupus erythematosus.
    Steinsson K; McLean RH; Merrow M; Rothfield NF; Weinstein A
    J Rheumatol; 1983 Aug; 10(4):590-4. PubMed ID: 6413687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired monocyte motility in sera from patients with systemic lupus erythematosus.
    Sturfelt G; Linder C; Sjöholm AG; Svensson B
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):151-8. PubMed ID: 6880748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.